neurodegenerative


Also found in: Medical, Encyclopedia, Wikipedia.

neu·ro·de·gen·er·a·tive

 (no͝or′ō-dĭ-jĕn′ər-ə-tĭv, nyo͝or′-)
adj.
Of, relating to, or characterized by a progressive loss of neurons in the brain: neurodegenerative diseases.
References in periodicals archive ?
AbbVie (ABBV) and Voyager Therapeutics (VYGR) announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
Lonza Pharma & Biotech and Denali Therapeutics announced an exclusive strategic partnership on Denalis biologic pipeline products for neurodegenerative diseases.
M2 PHARMA-January 9, 2018-Takeda, Denali Partner to Develop, Commercialise Neurodegenerative Disease Therapies
Takeda Pharmaceutical Company Ltd (TSE: 4502) and Denali Therapeutics (NASDAQ: DNLI) have entered into a strategic option and collaboration agreement for neurodegenerative diseases, the two firms announced on Friday.
NFTs, which are made up of aggregated tau protein, are a hallmark of several neurodegenerative diseases, including Alzheimer's disease.
Pulsus group is organizing 6th International Conference on Neurodegenerative Disorders and Stroke to be held on July 05-06, 2018 in Vienna, Austria where all the participants from whole around the world are invited to participate.
NEW ORLEANS - The use of metformin for at least 2 years had a protective effect on the incidence of neurodegenerative disease among elderly veterans, according to results from a large analysis of Veterans Affairs data.
com)-- Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells.
NESS ZION A, Israel, August 4, 2014 -- Israeli biotechnology company Kadimastem (TASE: KDST) reports that it has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases space for multiple sclerosis (MS), and potential other neurodegenerative diseases.
NESS ZIONA, Israel, August 4, 2014 -- Israeli biotechnology company Kadimastem (TASE: KDST) has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases space for multiple sclerosis (MS), and potential other neurodegenerative diseases.
Numerous lines of evidence indicate that chronic inflammation plays a major role in the development of various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, brain tumor, and meningitis.
The same protein that, in an altered shape, causes mad cow disease and other neurodegenerative disorders maintains the body's cache of blood-producing stem cells, a new study suggests.